Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

37.37 +0.49 (+1.33%)
Streaming Delayed Price Updated: 11:44 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Smith & Nephew SNATS, Inc. Common Stock

< Previous 1 2 3 4 Next >
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
From Smith & Nephew UK Ltd
Via GlobeNewswire
Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System
From Smith & Nephew UK Ltd
Via GlobeNewswire
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board
From Smith & Nephew UK Ltd
Via GlobeNewswire
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
Via Benzinga
Macy's, Koss And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge
Smith & Nephew shares rise as Cevian Capital acquires a 5% stake, aiming to improve operational performance. The medical tech firm faces challenges with declining market cap and mixed revenue growth. 
Via Benzinga
Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System
From Smith & Nephew UK Ltd
Via GlobeNewswire
4 Stocks to Watch in the Booming Regenerative Medicine Market
Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than... 
Via TheNewswire.com
4 Stocks to Watch in the Booming Regenerative Medicine Market
4 Stocks to Watch in the Booming Regenerative Medicine Market 
Via News Direct
Current Analysis: Smith & Nephew
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from... 
Via Talk Markets
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
From Smith & Nephew UK Ltd
Via GlobeNewswire
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism
Smith & Nephew shakes up executive pay structure, aligning with US standards to curb turnover. Chairman Rupert Soames addresses global talent recruitment challenges and the shift's significance in the... 
Via Benzinga
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
From Smith & Nephew UK Ltd
Via GlobeNewswire
3 Millionaire-Maker Robotics Stocks to Buy in February 2024
Jump into the future with top robotics stocks poised for explosive growth. Discover the potential for massive returns. 
Via InvestorPlace
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
From Smith & Nephew UK Ltd
Via GlobeNewswire
Santa Rally comes early for these stocks
The analysts are upgrading these stocks and are helping an early Santa Claus Rally drive their prices to new highs, with a double-digit upside ahead. 
Via MarketBeat
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell... 
Via Benzinga
Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength
Smith & Nephew PLC (NYSE: SNN) reported improved revenue, profit, and margin in the  
Via Benzinga
AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares... 
Via Benzinga
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.